Can Non-FDA Approved Peptides Trigger ERISA Oversight in Employer Wellness Offerings?
The regulatory environment scrutinizes unapproved peptides in group plans because individual biological needs conflict with the fiduciary duty of prudence.
HRTioOctober 14, 2025